| dc.description.abstract | Corporate Social Responsibility (CSR) has become an essential aspect of the business
strategy for pharmaceutical companies worldwide, including in Bangladesh. This study
examines the CSR practices of three leading pharmaceutical companies-Square
Pharmaceuticals Ltd., Beximco Pharmaceuticals Ltd., and ACI Pharmaceuticals Ltd. to
understand their contributions to healthcare, social development, and environmental
sustainability. The research employs a combination of case studies, secondary data
analysis, and stakeholder insights to evaluate the impact and challenges of CSR
initiatives in the pharmaceutical sector.
Findings reveal that these companies have significantly contributed to improving
healthcare access, promoting education, and adopting sustainable practices. Their CSR
efforts have enhanced their corporate reputation, customer loyalty, and business
performance, demonstrating a strong alignment between social responsibility and
commercial success. However, the study identifies challenges in measuring the long
term impact and sustaining these initiatives amid evolving societal and regulatory
demands. The research also highlights emerging trends, such as the integration of
innovation and technology in CSR, and increasing stakeholder expectations, which will
shape the future of CSR in the pharmaceutical industry.
This study offers recommendations for policymakers and companies to enhance CSR
practices, emphasizing transparency, collaboration, and sustainable development. It
provides valuable insights into how CSR can drive positive change in society while
ensuring the sustainable growth of the pharmaceutical industry in Bangladesh | en_US |
